The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Benjamin Garmezy
Consulting or Advisory Role - Abbvie (Inst); Adaptimmune (Inst); Adicent Therapeutics (Inst); AIQ Global (Inst); Amgen (Inst); Arcus Biosciences (Inst); Arvinas (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); EMD Serono (Inst); Exelixis (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Monte Rosa Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Rondo Therapeutics (Inst); Seagen (Inst); Specialty Networks (Inst); Takeda (Inst); Xencor (Inst)
Research Funding - Abbvie (Inst); Accutar Biotech (Inst); Adcentrx Therapeutics (Inst); Adicet Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Arvinas (Inst); AstraZeneca (Inst); Avenzo Therapeutics (Inst); AVEO (Inst); Bicycle Therapeutics (Inst); crispr therapeutics (Inst); Eikon Therapuetics (Inst); Envision Pharma Group (Inst); Exelixis (Inst); Flare Therapeutics (Inst); Halda Therapeutics (Inst); Harbour BioMed (Inst); HiberCell (Inst); IDEAYA Biosciences (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Jubilant Therapeutics (Inst); Kineta (Inst); Kinnate Biopharma (Inst); Loxo (Inst); Merck (Inst); MiNK Therapeutics (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); ProfoundBio (Inst); Roche/Genentech (Inst); Takeda (Inst); Teon Therapeutics (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst); Zenshine (Inst)
 
Manpreet Kaur
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Elaine Chen
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Katja Rueger
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Udaya Rangaswamy
Employment - Amgen; Rondo therapeutics
Stock and Other Ownership Interests - Rondo therapeutics; TBio LLC
 
Laura Davison
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Imani Smith
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Ruth Chu
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Soumili Chattopadhyay
Employment - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
 
Starlynn Clarke
No Relationships to Disclose
 
Katherine Harris
Employment - Amgen; Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics; TBio, LLC
 
Shelley Force Aldred
Employment - Rondo Therapeutics, Inc.
Leadership - Rondo Therapeutics, Inc.
Stock and Other Ownership Interests - Rondo Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - All inventions assigned to Rondo Therapeutics, Inc. - my employer
 
Nathan Trinklein
Employment - Rondo Therapeutics
Leadership - Rondo Therapeutics
Stock and Other Ownership Interests - Rondo Therapeutics
Patents, Royalties, Other Intellectual Property - I was an inventor on patents assigned to Teneobio and Rondo Therapeutics
 
Lynnae Jackson
Employment - Iambic Therapeutics; Rondo Therapeutics
Stock and Other Ownership Interests - Iambic Therapeutics; Rondo Therapeutics
Travel, Accommodations, Expenses - Iambic Therapeutics; Rondo Therapeutics
 
Thomas Manley
Employment - IgM Biosciences; Rondo Therapeutics
Leadership - Rondo Therapeutics
Stock and Other Ownership Interests - IgM Biosciences; Rondo Therapeutics
Patents, Royalties, Other Intellectual Property - IgM Biosciences
 
John Powderly
Employment - BioCytics; Carolina BioOncology Institute
Leadership - BioCytics; Carolina BioOncology Institute
Stock and Other Ownership Interests - BioCytics; Carolina BioOncology Institute
Consulting or Advisory Role - Aavocyte; Abbvie; AstraZeneca/MedImmune; Boxer Capital; Genentech/Roche; Phanes Therapeutics; TERUMO; TopAlliance BioSciences Inc
Research Funding - Abbvie; Adagene (Inst); Alkermes; Allarity Therapeutics (Inst); Apros Therapeutics; Aptevo Therapeutics (Inst); Arcus Biosciences; Arvinas; Arvinas; Ascendis Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune; Atreca (Inst); Aulos Bioscience (Inst); Axion BioTherapeutics (Instil Bio); BioBank Online (Inst); BioNTech SE (Inst); BJ Bioscience (Inst); Bright Peak Therapeutics; Bristol-Myers Squibb; Calico; Cellgene Corp. (Inst); CEM Corporation (Inst); Conjupro Biotherapeutics (Inst); Corbus Pharmaceuticals (Inst); Corvus Pharmaceuticals; CUE BioPharma (Inst); Cullinan Oncology (Inst); Curis; CytomX Therapeutics; DAAN Biotherapeutics; Duality Biologics; EMD Serono; Engineered BioPharmaceuticals (Inst); Ensem; Exelixis; Fate Therapeutics (Inst); FLX Bio; Function Oncology (Inst); Genentech/Roche; GI Innovation (Inst); Glenmark Specialty SA (Inst); Harbour BioMed (Inst); I-Mab (Inst); IconOVir Bio (Inst); IgM Biosciences (Inst); Immune-Onc Therapeutics (Inst); Incyte; Jounce Therapeutics; Lilly/ImClone; Macrogenics; MBrace Therapeutics Inc. (Inst); Medikine (Inst); Merck (Inst); Modena TX (Inst); Molecular Templates (Inst); MT Group (Inst); Multitude Therapeutics Inc (Inst); NextCure (Inst); Nuvation Bio (Inst); PBD Biologics LTD (Inst); PEEL Therapeutics (Inst); Phanes Therapeutics (Inst); Pieris Pharmaceuticals (Inst); Pioma Chemicals (Inst); Precision for Medicine (Inst); Qurgen (Inst); Repertoire Immune Medicines (Inst); Replimune (Inst); Revolution Medicines Inc. (Inst); RiboScience (Inst); Rondo; Sairopa (Inst); Seagen; Sequenom (Inst); Simcere (Inst); SK Life Sciences (Inst); STEMCELL Technologies (Inst); Tasca; Tempest Therapeutics; Terramoto; Teva; Therapeutic BrainPower LLC (Inst); Top Alliance BioScience; Trethera (Inst); Xilio Therapeutics (Inst); Xilis (Inst); Zenshine (Inst)
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy